PubMed 37364590 Regulatory status: Cagrilintide is not an approved human medicinal product in any regulatory zone (FDA, EMA, KL) as of the publication date
It stimulates the release of growth hormone, which in turn helps break down stored fat while promoting muscle development
When to seek medical care A person should seek medical care if they have ongoing fatigue, unexplained weight loss, jaundice, shortness of breath, persistent digestive symptoms, or signs of chronic illness
Off-label use of drugs in children
A Systematic review of semaglutides influence on cognitive function in preclinical animal models and cell-line studies
found that epithalon lengthened telomeres and stimulated telomerase following its introduction into telomerase-negative human fetal fibroblast cultures